Day: April 7, 2025
Pharmaceutical
Sci&Tech
Why Nav1.8 inhibitor is non-addictive pain killer
Journavx (VX-548, Suzetrigine) was approved in 2025 as the only new non-opoid painkiller in the past two decades. As we know it is a Nav1.8 inibitor, here we explain why Nav1.8 inhibitors won’t cause addiction(Disclaimer: based on the...